Seres Therapeutics Inc
MCRB
$2.71+3.04%
End of day · as of Oct 10, 2026, 8:01 AM ET
Mkt cap
$109.77M
EV/Sales
81.1
P/E ratio
N/A
FY2025 Revenue
$789,000
EPS (H1 2026)
$-1.59
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
721.93%
Beta
2.62
Div yield
N/A
Sector
Healthcare
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
Latest reported MCRB revenue for 2025-12-31 was $789.0K. Net income was $5.7M. MCRB currently screens at market cap $109.8M.
Use this MCRB research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full MCRB income, balance, and cash tables.
Seres Therapeutics Inc (MCRB) is a biotechnology company in the Healthcare sector.
Latest cached Seres Therapeutics Inc (MCRB) revenue for Dec 31, 2025 was $789.0K. Net income was $5.7M. Statements: https://lician.com/financials/mcrb
Seres Therapeutics Inc (MCRB) market capitalization is $109.8M on the latest cached snapshot.
Seres Therapeutics Inc (MCRB) cached previous close $2.63; day range $2.58 – $2.75; volume 79,407. Session quote: https://lician.com/quote/mcrb
Seres Therapeutics Inc (MCRB) latest cached earnings event is "MCRB earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached MCRB filing is 8-K · Aug 5, 2026. Filings: https://lician.com/sec/mcrb